Frequently Asked Questions

As a non-US company, investors in the United States have utilized the Roche ADR program since 1992. Here are answers to some of the most frequently asked questions from investors:

General Questions

American Depositary Receipts (ADRs)

Download the Roche ADR Backgrounder for more information.

Investing in Roche

Contact Us

Share Information

Reasons to Invest

Years of combined expertise in biotech, pharma, and diagnostics
New molecule entities in the pipeline
Years in a row of increased dividends